Balance is the digital clinical platform specialised in the comprehensive treatment of obesity with GLP-1.
Balance has raised €3.0M across 1 funding round from 4 investors, most recently a Seed round in Jul 2026. Based in Madrid, Spain; active in Healthtech. Data as of 6 Jul 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-06 | Seed | €3.0M |
| Atresmedia Capital,Business Angels,JME Ventures,Shilling VC |
| View deal → |
